Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colm Morrissey

Showing results (111-120 of 172) with videos related to

Pageof 18
Sort By:
Cancer Research|April 7, 2019
Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate CancerShangze Li, Ka-Wing Fong, Galina Gritsina, et al.
Cancer Discovery|August 15, 2014
The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasisJared M Lucas, Cynthia Heinlein, Tom Kim, et al.
The Prostate|March 19, 2016
Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancerMartine P Roudier, Brian R Winters, Ilsa Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2015
SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate CancerXiaotun Zhang, Ilsa M Coleman, Lisha G Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5-SN38 Antibody-drug Conjugate in Neuroendocrine Prostate CancerDiana C DeLucia, Thomas M Cardillo, Lisa Ang, et al.
Oncogene|March 8, 2018
Regulation of inside-out β1-integrin activation by CDCP1Sara G Pollan, Fangjin Huang, Jamie M Sperger, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2011
Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancersAkash Kumar, Thomas A White, Alexandra P MacKenzie, et al.
Molecular Cancer Research : MCR|January 13, 2016
Cells Comprising the Prostate Cancer Microenvironment Lack Recurrent Clonal Somatic Genomic AberrationsDaniella Bianchi-Frias, Ryan Basom, Jeffrey J Delrow, et al.
Nature Communications|November 30, 2016
Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancerChristine Henzler, Yingming Li, Rendong Yang, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategiesSander Frank, Thomas Persse, Ilsa Coleman, et al.
Pageof 18

Showing results (111-120 of 172) with videos related to

Sort By:
Pageof 18
Cancer Research|April 7, 2019
Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate CancerShangze Li, Ka-Wing Fong, Galina Gritsina, et al.
Cancer Discovery|August 15, 2014
The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasisJared M Lucas, Cynthia Heinlein, Tom Kim, et al.
The Prostate|March 19, 2016
Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancerMartine P Roudier, Brian R Winters, Ilsa Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2015
SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate CancerXiaotun Zhang, Ilsa M Coleman, Lisha G Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5-SN38 Antibody-drug Conjugate in Neuroendocrine Prostate CancerDiana C DeLucia, Thomas M Cardillo, Lisa Ang, et al.
Oncogene|March 8, 2018
Regulation of inside-out β1-integrin activation by CDCP1Sara G Pollan, Fangjin Huang, Jamie M Sperger, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2011
Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancersAkash Kumar, Thomas A White, Alexandra P MacKenzie, et al.
Molecular Cancer Research : MCR|January 13, 2016
Cells Comprising the Prostate Cancer Microenvironment Lack Recurrent Clonal Somatic Genomic AberrationsDaniella Bianchi-Frias, Ryan Basom, Jeffrey J Delrow, et al.
Nature Communications|November 30, 2016
Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancerChristine Henzler, Yingming Li, Rendong Yang, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategiesSander Frank, Thomas Persse, Ilsa Coleman, et al.
Pageof 18